Skip to main content
SpringerLink
Log in

Persistent Hypogammaglobulinemia Following Mononucleosis in Boys Is Highly Suggestive of X-Linked Lymphoproliferative Disease—Report of Three Cases

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Hypogammaglobulinemia is a common symptom in different immunodeficiencies. It is, however, not usually associated with Epstein–Barr virus (EBV) infections. The X-linked lymphoproliferative disease (XLP) on the other hand shows immunological changes in response to the EBV. Here we report three previously healthy boys, all of which developed persistent hypogammaglobulinemia following severe acute infectious mononucleosis. All three patients revealed T-cell abnormalities including inverted CD4/CD8 and increased CD8+ T-cell numbers. The number of IFN-γ-producing T cells were markedly increased in the two patients studied so far. In addition, patient 2 showed mainly T cells, instead of B cells, to be infected with the EBV. Apart from an uncle of patient 3, who died of malignant lymphoma, family history was unremarkable in all cases. All three patients exhibited mutations in the SH2D1A gene, establishing the diagnosis of XLP. Protein expression was found on immunoblot analysis in one patient with a missense mutation. Development of persistent hypogammaglobulinemia after severe primary EBV infection seems to be a specific diagnostic sign for XLP even in males with unremarkable family history.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Sumaya CV: Primary Epstein–Barr virus infections in children. Pediatrics 59:16–21, 1977

    PubMed  Google Scholar 

  2. Cohen JI: Epstein–Barr virus infection. N Engl J Med 343:481–492, 2000

    PubMed  Google Scholar 

  3. Baumgarten E, Herbst H, Schmitt M, Seeger KH, Schulte-Overberg U, Henze G: Life-threatening infectious mononucleosis: Is it correlated with virus-induced Tcell proliferation? Clin Infect Dis 19:152–156, 1994

    PubMed  Google Scholar 

  4. Brandau O, Schuster V, Weiss M, Hellebrand H, Fink FM, Kreczy A, Friedrich W, Strahm B, Niemeyer C, Belohradsky BH, Meindl A: Epstein–Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lympho-proliferative disease (XLP). Hum Mol Genet 8:2407–2413, 1999

    PubMed  Google Scholar 

  5. Schuster V, Kress W, Friedrich W, Grimm T, Kreth HW: X-linked lymphoproliferative disease. Detection of a paternally inherited mu-tation in a German family using haplotype analysis. Am J Dis Child 147:1303–1305, 1993

    PubMed  Google Scholar 

  6. Pala P, Hussell T, Openshaw P: Flow cytometric measurement of intracellular cytokines. J Immunol Methods 243:107–124, 2000

    PubMed  Google Scholar 

  7. Zuccaro G, Della Bella S, Polizzi B, Vanoli M, Scorza R: Common variable immunodeficiency following Epstein–Barr virus infection. J Clin Lab Immunol 49:41–45, 1997

    PubMed  Google Scholar 

  8. Lanning M, Kouvalainen K, Simila S, Raunio V: Agammaglobu-linemia with arthritis and celiac disease developing after infectious mononucleosis. Follow-up study of a case. Scand J Infect Dis 9:144–148, 1977

    PubMed  Google Scholar 

  9. Purtilo D, Cassel C, Yang J, Harper R: X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1:1935–1940, 1975

    Google Scholar 

  10. Schuster V, Kreth H: X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein. Immunol Rev 178:21–28, 2000

    PubMed  Google Scholar 

  11. Grierson H, Purtilo D: Epstein–Barr virus infections in males with the X-linked lymphoproliferative syndrome. Ann Intern Med 106:538–545, 1987

    PubMed  Google Scholar 

  12. Schuster V, Steppberger K, Borte M: Manifestations of X-linked lymphoproliferative disease without prior Epstein–Barr virus exposure. Blood 98:1986, 2001

    PubMed  Google Scholar 

  13. Coffey A, Brooksbank R, Brandau O, Oohashi T, Howell G, Bye J, Cahn A, Durham J, Heath P, Wray P, Pavitt R, Wilkinson J, Leversha M, Huckle E, Shaw-Smith C, Dunham A, Rhodes S, Schuster V, Porta G, Yin L, Serafini P, Sylla B, Zollo M, Franco B, Bolino A, Seri M, Lanyi A, Davis J, Webster D, Harrs A, Lenoir G, Basile GdS, Jones A, Behloradsky B, Achats H, Murken J, Fassler R, Sumegi J, Romeo G, Vaudin M, Ross M, Meindl A, Bentley D: Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 20:129–135, 1998

    PubMed  Google Scholar 

  14. Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, Schaik Sv, Notarangelo L, Geha R, Roncarolo M, Oettgen H, Vries JD, Aversa G, Terhorst C: The X-linked lymphoproliferative disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395:462–469, 1998

    PubMed  Google Scholar 

  15. Wu C, Nguyen K, Pien G, Wang N, Gullo C, Howie D, Sosa M, Edwards M, Borrow P, Satoskar A, Sharpe A, Biron C, Terhorst C: SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nat Immunol 2:410–414, 2001

    PubMed  Google Scholar 

  16. Mehta VK, Massad MG, Tripathi SP, Koshy M, Geha AS: Immune-deficient bronchiectasis associated with X-linked lymphoprolifera-tive disease. Ann Thorac Surg 68:578–580, 1999

    PubMed  Google Scholar 

  17. Yin L, Ferrand V, Lavoue MF, Hayoz D, Philippe N, Souillet G, Seri M, Giacchino R, Castagnola E, Hodgson S, Sylla BS, Romeo G: SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients. Hum Genet 105:501–505, 1999

    PubMed  Google Scholar 

  18. Nistala K, Gilmour KC, Cranston T, Davies EG, Goldblatt D, Gaspar HB, Jones AM: X-linked lymphoproliferative disease: Three atypical cases. Clin Exp Immunol 126:126–130, 2001

    PubMed  Google Scholar 

  19. Arico M, Imashuku S, Clementi R, Hibi S, Teramura T, Danesino C, Haber DA, Nichols KE: Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene. Blood 97:1131–1133, 2001

    PubMed  Google Scholar 

  20. Schuster V, Terhorst C: A defective SH2D1A gene causes X-linked lymphoproliferative disease (XLP) (Chapter 32). In Primary Immun-odeficiency Diseases, a Molecular and Genetic Approach, J Puck (eds). Oxford, Oxford University Press, in press, 2004

    Google Scholar 

  21. Sumegi J, Huang D, Lanyi A, Davis JD, Seemayer TA, Maeda A, Klein G, Seri M, Wakiguchi H, Purtilo DT, Gross TG: Correlation of mutations of the SH2D1A gene and Epstein–Barr virus infection with clinical phenotype and outcome in X-linked lymphoprolifera-tive disease. Blood 96:3118–3125, 2000

    PubMed  Google Scholar 

  22. Shinozaki K, Kanegane H, Matsukura H, Sumazaki R, Tsuchida M, Makita M, Kimoto Y, Kanai R, Tsumura K, Kondoh T, Moriuchi H, Miyawaki T: Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection. Int Immunol 14:1215–1223, 2002

    PubMed  Google Scholar 

  23. Parolini O, Kagerbauerl B, Simonitsch-Klupp I, Ambros P, Jaeger U, Mann G, Haas OA, Morra M, Gadner H, Terhorst C, Knapp W, Holter W: Analysis of SH2D1A mutations in patients with severe Epstein–Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma. Ann Hematol 81:441–447, 2002

    PubMed  Google Scholar 

  24. Schuster V, Kreth HW: X-linked lymphoproliferative disease is caused by deficiency of a novel SH2-domain containing signal transduction adaptor protein (SH2D1A). Immunol Rev 178:21–28, 2000

    PubMed  Google Scholar 

  25. Sumazaki R, Kanegane H, Osaki M, Fukushima T, Tsuchida M, Matsukara H, Shinozaki K, Kimura H, Matsui A, Miyawaki T: SH2D1A mutations in Japanese males with severe Epstein–Barr virus-associated illnesses. Blood 98:1268–1270, 2001

    PubMed  Google Scholar 

  26. Gaspar HB, Sharifi R, Gilmour KC, Thrasher AJ: X-linked lympho-proliferative disease: Clinical, diagnostic and molecular perspective. Br J Haematol 119:585–595, 2002

    PubMed  Google Scholar 

  27. Morra M, Simarro-Grande M, Martin M, Chen AS, Lanyi A, Silander O, Calpe S, Davis J, Pawson T, Eck MJ, Sumegi J, Engel P, Li SC, Terhorst C: Characterization of SH2D1A missense mu-tations identified in X-linked lymphoproliferative disease patients. J Biol Chem 276:36809–36816, 2001

    PubMed  Google Scholar 

  28. Kurth J, Spieker T, Wustrow J, Strickler GJ, Hansmann LM, Rajewsky K, Kuppers R: EBV-infected Bcells in infectious mononu-cleosis: Viral strategies for spreading in the B cell compartment and establishing latency. Immunity 13:485–495, 2000

    PubMed  Google Scholar 

  29. Mori M, Kourozomi H, Akagi K, Tanaka Y, Imai S, Osato T: Mono-clonal proliferation of T cells containing Epstein–Barr virus in fatal mononucleosis. N Engl J Med 327:58, 1992

    Google Scholar 

  30. Kasahara Y, Yachie A, Takei K, Kanegane C, Okada K, Ohta K, Seki H, Igarashi N, Maruhashi K, Katayama K, Katoh E, Terao G, Sakiyama Y, Koizumi S: Differential cellular targets of Epstein–Barr virus (EBV) infection between acute EBV-associated hemophago-cytic lymphohistiocytosis and chronic active EBV infection. Blood 98:1882–1888, 2001

    PubMed  Google Scholar 

  31. Ohga S, Nomura A, Takada H, Ihara K, Kawakami K, Yanai F, Takahata Y, Tanaka T, Kasuga N, Hara T: Epstein–Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection. J Infect Dis 18:1–7, 2001

    Google Scholar 

  32. Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciotto CG, Wahl R, Sands J, Gottmann D, Katz BZ, Sklar J: T-cell lymphomas containing Epstein–Barr viral DNA in patients with chronic Epstein–Barr virus infections. N Engl J Med 318:733–741, 1988

    PubMed  Google Scholar 

  33. Imai S, Suguira M, Oikawa O, Koizumi S, Hirao M, Kimura H, Hayashibara H, Terai N, Tutsumi H, Oda T, Chiba S, Osato T: Epstein–Barr virus (EBV)-carrying and-expressing T-cell lines es-tablished from severe chronic active EBV infection. Blood 87:1446–1457, 1996

    PubMed  Google Scholar 

  34. Seemayer TA, Gross TG, Egeler RM, Pirrucello SJ, Davis JR, Kelly CM, Okano M, Lanyi A, Sumegi J: X-linked lymphoproliferative disease: Twenty-five years after the discovery. Pediatr Res 38:471–478, 1995

    PubMed  Google Scholar 

  35. Strahm B, Rittweiler K, Duffner U, Brandau O, Orlowska-Volk M, Karajannis MA, Stadt UZ, Tiemann M, Reiter A, Brandis M, Meindl A, Niemeyer C: Recurrent B-cell non-Hodgkin's lymphoma in two brothers with X-linked lymphoproliferative disease without evidence for Epstein–Barr virus infection. Br J Haematol 108:377–382, 2000

    PubMed  Google Scholar 

  36. Kilic S, Tezcan I, Sanal O, Ersoy F: Common variable immunodefi-ciency in a patient with neurofibromatosis. Pediatr Int 43:691–693, 2001

    PubMed  Google Scholar 

  37. Crotty S, Kersh EN, Cannons J, Schwarzmann F, Ahmed R: SAP is required for generating long-term humoral immunity. Nature 421:282–287, 2003

    PubMed  Google Scholar 

  38. Malbran A, Belmonte L, Ruibal-Ares B, Bare P, Massud I, Parodi C, Fellipo M, Hodinka R, Haines K, Nichols KE, De Bracco M: Loss of circulating CD27 +memory B cells and CCR4 +T cells occuring in association with elevated Epstein–Barr virus (EBV) loads in XLP patients surviving primary EBV infection. Blood 103:1625–1634, 2004

    PubMed  Google Scholar 

  39. Yasuda N, Lai PK, Rogers J, Purtlo DT: Defective control of Epstein– Barr virus-infected B cell growth in patients with X-linked lympho-proliferative disease. Clin Exp Immunol 83:10–16, 1991

    PubMed  Google Scholar 

  40. Lai PK, Yasuda N, Purtilo DT: Immunoregulatory T cells in males vulnerable to Epstein–Barr virus with the X-linked lymphopro-liferative syndrome. Am J Pediatr Hematol Oncol 9:179–182, 1987

    PubMed  Google Scholar 

  41. Wu C, Nguyen KB, Pien GC, Wang N, Gullo C, Howie D, Sosa MR, Edwards MJ, Borrow P, Satoskar AR, Sharpe AH, Biron CA, Terhorst C: SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nat Immunol 2:410–414, 2001

    PubMed  Google Scholar 

  42. Ehl S, Peters A, Strahm B, Schlesier M, Orlowska-Volk M, Kopp M, Gilmour KC, Gaspar HB, Niemeyer CM: Detailed immunological characterization of a boy with atypical Purtilo syndrome. In Proceed-ings of the 10th Meeting of the European Society for Immunode-ficiencies ESID, Weimar Oct 17–20, 2002. ESID Newsletter 2002; Suppl S62, 2002

Download references

Author information

Authors and Affiliations

  1. Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany

    B. Hügle, P. Suchowerskyj & V. Schuster

  2. Department of Medical Genetics, LMU, Munich, Germany

    H. Hellebrand

  3. Institute of Molecular Immunology, GSF – Forschungszentrum, Munich, Germany

    B. Adler

  4. Children's, Hospital St.Georg, Leipzig, Germany

    M. Borte

  5. Institute of Clinical Immunology and Transfusion Medicine, University of Leipzig, Leipzig, Germany

    U. Sack

  6. Children's, Hospital, Charité, Berlin, Germany

    U. Schulte Overberg-Schmidt

  7. Children's Hospital, University of Frankfurt, Frankfurt, Germany

    N. Strnad

  8. Children's Hospital for Airway Diseases and Allergies, Wangen, Germany

    J. Otto

  9. Department of Medical Genetics, LMU, Munich, Germany

    A. Meindl

Authors
  1. B. Hügle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Suchowerskyj
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Hellebrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Adler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Borte
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. U. Sack
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. U. Schulte Overberg-Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. N. Strnad
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J. Otto
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A. Meindl
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. V. Schuster
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hügle, B., Suchowerskyj, P., Hellebrand, H. et al. Persistent Hypogammaglobulinemia Following Mononucleosis in Boys Is Highly Suggestive of X-Linked Lymphoproliferative Disease—Report of Three Cases. J Clin Immunol 24, 515–522 (2004). https://doi.org/10.1023/B:JOCI.0000040922.26286.36

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:JOCI.0000040922.26286.36

Search

Navigation